Weill Cornell Medicine researchers have found that intracranial hemorrhages, or “brain bleeds” caused by a ruptured blood vessel in the brain, doubles a person’s risk of developing dementia later in life.
The White House has recognized six Cornell faculty members, three from the Ithaca campus and three from Weill Cornell Medicine, with 2025 Presidential Early Career Awards for Scientists and Engineers. The awards were announced Jan. 14.
Using machine learning technology, a new study has identified three distinct profiles describing social and economic factors that are associated with a higher risk of suicide.
Weill Cornell Medicine and the Cornell Jeb E. Brooks School of Public Policy have established the Cornell Health Policy Center to serve as the locus for health policy impact, research and training across Cornell.
The MyCoast New York app has already provided forecasters and emergency managers with a new understanding of flooding around the state, as sea levels rise and storms intensify.
Backslash at Cornell Tech, dedicated to advancing new works of art and technology that escape convention, has announced Nigerian-American artist Mimi Onuoha as its first Backslash Fellow.
The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer called glioblastoma, suggests a new preclinical study from Weill Cornell Medicine researchers.
Sara Bronin is a professor of planning at Cornell University, an architect, attorney and founding director of the National Zoning Atlas. Her recent work with the Regional Plan Association analyzed the increasing risk of future flooding in New York City and how it may affect housing.
A new study has unveiled a precise picture of how an ion channel found in most mammalian cells regulates its own function with a “ball-and-chain” channel-plugging mechanism, according to investigators at Weill Cornell Medicine.
A multinational, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
